ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

NCT00678418 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Opiate Dependence

Interventions

DRUG: VIVITROL® 380 mg
DRUG: Placebo

Sponsor

Alkermes, Inc.